Initiation, adherence to AIs low for older women with DCIS
5 (212) · $ 14.00 · In stock
(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 in Cancer.
Breast Cancer
Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Early Stage Hormone Receptor Positive Breast Cancer - ScienceDirect
Adjuvant Hormonal Therapy Adherence in Breast Cancer - BCTT
Older Patients With Low-Risk DCIS May Not Benefit From Surgery, Radiation
Breast Cancer Treatment (PDQ®) - NCI
PDF) Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
Use of endocrine therapy following diagnosis of ductal carcinoma in situ or early invasive breast cancer - Data Points Publication Series - NCBI Bookshelf
Adjuvant Hormonal Therapy Adherence in Breast Cancer - BCTT
JBC :: Journal of Breast Cancer
Nainan Hei - Providence
